We are international
Donate
TEXT SIZE   


IMF PRESENTS THE KYLE LIFETIME ACHIEVEMENT AWARD TO MARIO BOCCADORO, MD, OF THE UNIVERSITY OF TORINO, ITALY
Founded the Italian Myeloma Study Group, a Pioneering Investigator Consortium in Europe
02.06.08

--Founded the Italian Myeloma Study Group, a Pioneering Investigator Consortium in Europe--

North Hollywood, CA and Würzburg, Germany, February 6, 2008 – The International Myeloma Foundation (IMF) – supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians – today presented the sixth annual Robert A. Kyle Lifetime Achievement Award to Mario Boccadoro, M.D., Head of the Hematology section of the Oncology division at the University of Torino. Professor Boccadoro created the Italian Myeloma Study Group (MSG), the first myeloma research consortium in Italy and among the first such groups in Europe. The Kyle Lifetime Achievement Award honors the physician who most exemplifies a singular compassion to patients with myeloma and dedication to their treatment.

The award was presented February 6, 2008 during a special award ceremony given in Prof. Boccadoro's honor at the Palazzina di Caccia Stupinigi. This historic venue built in 1729 for King Vittorio Amedeo II was a prefect setting for such a prestigious event. The VI Annual Robert A. Kyle Lifetime Achievement Award dinner coincided with the European Trialist Forum on blood cancers which also took place in Torino.

Under Prof. Boccadoro's direction, the MSG has conducted a series of pivotal clinical trials including pioneering work on stem cell transplantation, and studies covering the range of promising novel agents: thalidomide, REVLIMID®, and VELCADE®. Among Prof. Boccadoro's recent accomplishments are combining melphalan/prednisone (MP) with thalidomide, a regimen he developed with Antonio Palumbo that is achieving excellent results. More recently his work has laid the groundwork for combining REVLIMID with MP, a regimen that appears to be even more effective in studies now underway.

"Mario has had a remarkable and productive career, and his work exemplifies the commitment to patient care and improving patient outcomes that are the qualities recognized by this award," said Brian G.M. Durie, M.D., chairman and co-founder of the IMF. "His dedication to research and his numerous contributions to improving patients' lives mirror the admirable pursuits of Dr. Robert A. Kyle, for whom this award is named.

"Prof. Boccadoro began his association with myeloma in 1978 when, as a post-doctoral fellow in Brussels he began working with Prof. Benjamin Van Camp, one of the early researchers in the field. Subsequently, he was appointed assistant professor at the University of Torino in the department of Prof. Allessandro Pileri, a noted researcher in the area of multiple myeloma. In the early 1980s, Prof. Boccadoro spent two years at the Arizona Cancer Center in Tucson as a visiting investigator where he worked with Dr. Durie and Dr. Sydney Salmon, co-developers of the Durie/Salmon Staging System for myeloma. Since 2000, he has been Professor and Head of the Hematology section of the Oncology division at the University of Torino.

Prof. Boccadoro's well-respected trials have been published in major journals including, The New England Journal of Medicine, Blood and the Journal of Clinical Oncology. He is a member of numerous professional societies both in Europe and in the United States.

The prestigious award is named after Dr. Robert A. Kyle, noted physician and founder of the Myeloma and Related Diseases Research Group at the Mayo Clinic in Rochester, Minnesota. Dr. Kyle himself was the first recipient of the award in 2003. Subsequently, the award has been presented to Dr. Bart Barlogie of the Myeloma Institute for Research and Therapy, Dr. Kenneth Anderson of the Dana Farber Cancer Institute, Dr. Brian G.M. Durie of the Cedars Sinai Comprehensive Cancer Center, and Prof. Dr. Heinz Ludwig, of the Center of Oncology and Hematology, Wilheminenspital, Vienna.

ABOUT The International Myeloma Foundation
The International Myeloma Foundation is the oldest and largest myeloma organization, reaching more than 165,000 members in 113 countries worldwide.  A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses in four key areas: research, education, support and advocacy. To date, the IMF has conducted more than 100 educational seminars worldwide, maintains a world-renowned hotline, and operates Bank On A Cure®, a unique gene bank to advance myeloma research. The IMF can be reached at (800) 452-CURE. The global Website is www.myeloma.org with a companion Website in Spanish at www.myelomala.org.

Contact:
International Myeloma Foundation
800-452-2873
Media:
Stephen Gendel
+1 212-918-4650


 related articles
Antonio Palumbo, MD
History of the Robert A. Kyle Lifetime Achievement Award
Gösta Gahrton, MD
Tenth Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Jesús San-Miguel
Ninth Annual Robert A. Kyle Lifetime Achievement Award Presented to Douglas E. Joshua, AM
Eighth Robert A. Kyle Lifetime Achievement Award presented to Dr. Joan Bladé
Seventh Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Jean-Luc Harousseau
Sixth Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Mario Boccadoro
Fifth Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Dr. Heinz Ludwig
Fourth Annual Robert A. Kyle Lifetime Achievement Award presented to Dr. Brian G. M. Durie
Third Annual Robert A. Kyle Lifetime Achievement Award presented to Dr. Kenneth C. Anderson
Second Annual Robert A Kyle Lifetime Achievement Award presented to Dr. Bart Barlogie
First Annual Robert A. Kyle LIfetime Achievement Award Presented to the Man in Whose Honor it is Named


You might also be interested in:

This Year's Honoree
Antonio Palumbo, MD

In Recognition of Significant Contributions to Myeloma Research and Patient Care


About the Kyle Lifetime Achievement Award
History of the Robert A. Kyle Lifetime Achievement Award
Nearly a century ago, Dr. William Mayo set the standard for treatment of patients at Mayo Clinic with these words, "the needs of the patient are the only needs to be considered." In 2003, the IMF decided to bestow a Lifetime Achievement Award annually to a physician whose work against myeloma reflected the dedication and compassion inherent in Dr. Mayo's vow. The IMF chose to name this award for Robert A. Kyle, M.D., whose life and work give new meaning to these words.

Past Recipients
Gösta Gahrton, MD

The eleventh annual Robert A. Kyle Lifetime Achievement Award will be presented to Dr. Gösta Gahrton during a ceremony at the Grand Hotel in Stockholm, Sweden, on June 11, 2013.

"We applaud Dr. Gahrton’s accomplishments and decades-long contributions to improving the lives of myeloma patients," says IMF President and Co-Founder Susie Novis.

Dr. Gahrton is professor of medicine and head of the Department of Medicine at the Karolinska Institutet in Stockholm, Sweden.


Tenth Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Jesús San-Miguel
Prof. San-Miguel is Professor of Medicine (Haematology), head of the Haematology Department at the University Hospital of Salamanca, and Director of the Biomedical Research Institute of Salamanca, Spain.

Ninth Annual Robert A. Kyle Lifetime Achievement Award Presented to Douglas E. Joshua, AM

Prof. Joshua is Head of Clinical and Laboratory Haematology at Sydney Cancer Centre, Head of Sydney South Western Area Health Service Haematology, the Alan Ng Professor in Medicine at University of Sydney, and the Director of the Institute of Hematology, Royal Prince Alfred Hospital.

Prof. Joshua is the ninth Kyle Award winner, and will be honored in London on June 8, 2011.


Eighth Robert A. Kyle Lifetime Achievement Award presented to Dr. Joan Bladé
The setting for the evening was a Catalonian masia (a typical farmhouse of the region) called Can Travi Nou near the Vall d’Hebron Park in Barcelona. More than two hundred guests were in attendance to honor the lifelong dedication and commitment of Dr. Bladé to myeloma patients, their families, and to myeloma research.

Seventh Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Jean-Luc Harousseau
At the ceremony, Prof. Philippe Moreau, who has worked closely with Prof. Harousseu for many years, gave a moving speech about the importance of Prof. Harousseau’s contribution to the field of myeloma and his tremendous dedication to myeloma patients in France and around the world.

Sixth Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Mario Boccadoro
It was a night to remember as the IMF honored Prof. Mario Boccadoro with the Sixth Annual Robert A. Kyle Lifetime Achievement Award surrounded by his loving family, his many friends, and numerous colleagues.

Fifth Annual Robert A. Kyle Lifetime Achievement Award Presented to Prof. Dr. Heinz Ludwig
Prof. Ludwig was presented with this honor in recognition of his work in medical hematology-oncology and, in particular, multiple myeloma.The event took place in Vienna, Austria, on June 7, 2007, at the historic and beautiful Vienna Kursalon, famous for providing an exquisite venue for classical concerts, operas, and musicals.

Fourth Annual Robert A. Kyle Lifetime Achievement Award presented to Dr. Brian G. M. Durie
Carol Klein writes, "It was an...honor to be a part of a tribute to such a respected, brilliant, dedicated, and truly loved person as Dr. Brian Durie. Over the years, we have had the opportunity to learn of Brian's extensive education, experience and commitment to the myeloma community."

Third Annual Robert A. Kyle Lifetime Achievement Award presented to Dr. Kenneth C. Anderson
Dr. Anderson was selected for pioneering critical advances against multiple myeloma, leading not only to improved treatments but also to a deeper understanding of how myeloma occurs at the basic level of cells and genes.

Second Annual Robert A Kyle Lifetime Achievement Award presented to Dr. Bart Barlogie
Dr. Barlogie was honored for his outstanding body of work, both clinical and research, in the field of myeloma. One of the world's leading myeloma researchers, Dr. Barlogie has made a tremendous impact on patient treatment and care.

First Annual Robert A. Kyle LIfetime Achievement Award Presented to the Man in Whose Honor it is Named
Well wishers from around the world converged on sunny Rochester, Minnesota the first weekend of August to join the IMF in presenting its first Robert A. Kyle Lifetime Achievement Award to Dr. Kyle.